Weight loss was lower with a GLP-1 agonist than with bariatric surgery, in a small review article and meta-analysis, but researchers have yet to directly compare surgery with new dual or triple agonists.
An international group of honorees have been selected to present innovative research designs providing the latest insights into preventing and treating obesity during the 10th annual Obesity Journal Symposium.